Literature DB >> 35354983

Developing a cure for chronic hepatitis B requires a fresh approach.

Matteo Iannacone, Luca G Guidotti.   

Abstract

Entities:  

Keywords:  Diseases; Drug discovery; Medical research; Therapeutics

Mesh：

Substances：

Year:  2022        PMID： 35354983     DOI： 10.1038/d41586-022-00813-0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  9 in total

1.  Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice.

Authors:  Thomas Michler; Anna D Kosinska; Julia Festag; Till Bunse; Jinpeng Su; Marc Ringelhan; Hortenzia Imhof; Dirk Grimm; Katja Steiger; Carolin Mogler; Mathias Heikenwalder; Marie-Louise Michel; Carlos A Guzman; Stuart Milstein; Laura Sepp-Lorenzino; Percy Knolle; Ulrike Protzer
Journal:  Gastroenterology       Date:  2020-01-28       Impact factor: 22.682

2.  Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B.

Authors:  Patrick T F Kennedy; Elena Sandalova; Juandy Jo; Upkar Gill; Ines Ushiro-Lumb; Anthony T Tan; Sandhia Naik; Graham R Foster; Antonio Bertoletti
Journal:  Gastroenterology       Date:  2012-06-15       Impact factor: 22.682

3.  Effects of Hepatitis B Surface Antigen on Virus-Specific and Global T Cells in Patients With Chronic Hepatitis B Virus infection.

Authors:  Nina Le Bert; Upkar S Gill; Michelle Hong; Kamini Kunasegaran; Damien Z M Tan; Raidah Ahmad; Yang Cheng; Charles-A Dutertre; Andreas Heinecke; Laura Rivino; Anthony Tan; Navjyot K Hansi; Min Zhang; Sujuan Xi; Yutian Chong; Stefan Pflanz; Evan W Newell; Patrick T F Kennedy; Antonio Bertoletti
Journal:  Gastroenterology       Date:  2020-04-14       Impact factor: 22.682

4.  Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming.

Authors:  Giorgia De Simone; Francesco Andreata; Camille Bleriot; Valeria Fumagalli; Chiara Laura; José M Garcia-Manteiga; Pietro Di Lucia; Stefano Gilotto; Xenia Ficht; Federico F De Ponti; Elisa B Bono; Leonardo Giustini; Gioia Ambrosi; Marta Mainetti; Paola Zordan; Alexandre P Bénéchet; Micol Ravà; Svetoslav Chakarov; Federica Moalli; Marc Bajenoff; Luca G Guidotti; Florent Ginhoux; Matteo Iannacone
Journal:  Immunity       Date:  2021-08-31       Impact factor: 43.474

5.  New Therapeutics for Hepatitis B: The Road to Cure.

Authors:  Susanna Naggie; Anna S Lok
Journal:  Annu Rev Med       Date:  2020-10-21       Impact factor: 13.739

Review 6.  Immunobiology and pathogenesis of hepatitis B virus infection.

Authors:  Matteo Iannacone; Luca G Guidotti
Journal:  Nat Rev Immunol       Date:  2021-05-17       Impact factor: 53.106

7.  Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection.

Authors:  Elmira Aliabadi; Melanie Urbanek-Quaing; Benjamin Maasoumy; Birgit Bremer; Martin Grasshoff; Yang Li; Christian E Niehaus; Heiner Wedemeyer; Anke R M Kraft; Markus Cornberg
Journal:  Gut       Date:  2021-10-26       Impact factor: 31.793

8.  Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming.

Authors:  Alexandre P Bénéchet; Giorgia De Simone; Pietro Di Lucia; Francesco Cilenti; Giulia Barbiera; Nina Le Bert; Valeria Fumagalli; Eleonora Lusito; Federica Moalli; Valentina Bianchessi; Francesco Andreata; Paola Zordan; Elisa Bono; Leonardo Giustini; Weldy V Bonilla; Camille Bleriot; Kamini Kunasegaran; Gloria Gonzalez-Aseguinolaza; Daniel D Pinschewer; Patrick T F Kennedy; Luigi Naldini; Mirela Kuka; Florent Ginhoux; Alessio Cantore; Antonio Bertoletti; Renato Ostuni; Luca G Guidotti; Matteo Iannacone
Journal:  Nature       Date:  2019-10-02       Impact factor: 49.962

9.  Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection.

Authors:  Valeria Fumagalli; Pietro Di Lucia; Valentina Venzin; Elisa B Bono; Robert Jordan; Christian R Frey; William Delaney; Francis V Chisari; Luca G Guidotti; Matteo Iannacone
Journal:  J Exp Med       Date:  2020-11-02       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.